Clusterin is enriched in plaque‐associated astrocytes and localizes to synapses in Alzheimer's disease
Alzheimer's & Dementia · 2026-10 · 22 (10)
DOI: 10.1002/alz.71885 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 06.10.2026. Verfasst von Robert A J Byrne und 12 weiteren Autor:innen. Beteiligte Einrichtung: UK Dementia Research Institute, School of Medicine, Cardiff University, Cardiff, Wales, UK. Hauptthemen laut MEDLINE: Clusterin, Alzheimer Disease, Astrocytes, Synapses. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Research and Innovation, Alzheimer's Research UK.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION The clusterin gene ( CLU ) is a top genome‐wide association studies (GWAS) risk locus for Alzheimer's disease (AD) and elevated clusterin levels have been reported in AD biofluids and brain tissue. Despite growing interest in clusterin as a biomarker and therapeutic target, its cellular and subcellular localization in the human brain remains incompletely understood, in part due to a lack of well‐characterized reagents. METHODS We generated and validated monoclonal antibodies (mAbs) that distinguish secreted and intracellular clusterin, and applied these tools to human biofluids, brain tissue, and induced pluripotent stem cell (iPSC) ‐derived astrocytes. RESULTS The mAbs enabled sensitive detection and quantification of clusterin in plasma, serum, cerebrospinal fluid, and brain tissue homogenates. Immunostaining demonstrated that clusterin is associated with amyloid plaques in AD brain and localizes to synapses in both healthy and AD tissue; the mAb detecting intracellular clusterin demonstrated specific expression in astrocytes, confirmed using astrocytoma lines and iPSC‐derived astrocytes. Quantitative analysis demonstrated increased clusterin signal in plaque‐associated astrocytes, particularly those surrounding larger plaques. DISCUSSION The findings provide better understanding of clusterin expression in the healthy and AD brain, informing roles of clusterin in brain homeostasis and AD pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UK Dementia Research Institute, School of Medicine, Cardiff University, Cardiff, Wales, UK.
- Hodge Centre for Translational Neuroscience, School of Medicine, Cardiff University, Cardiff, Wales, UK.
ORCID-Profile: Nikoleta Daskoulidou
Förderung
- UK Research and Innovation
- Alzheimer's Research UK
Zitieren
APA
Byrne, R. A. J., Veteleanu, A., Cramp, H. L., Bacon, O. G., Baillie, K. L., Bright, M., Cooke, R. S., Fenn, G. D., Flores Castelán, M., Lee, K. Y., Zelek, W. M., Morgan, B. P., & Daskoulidou, N. (2026). Clusterin is enriched in plaque‐associated astrocytes and localizes to synapses in Alzheimer's disease. Alzheimer's & Dementia, 22(10). https://doi.org/10.1002/alz.71885
Vancouver
Byrne RAJ, Veteleanu A, Cramp HL, Bacon OG, Baillie KL, Bright M, et al. Clusterin is enriched in plaque‐associated astrocytes and localizes to synapses in Alzheimer's disease. Alzheimer's & Dementia. 2026;22(10). doi:10.1002/alz.71885
BibTeX
@article{Byrne2026,
author = {Byrne, Robert A J and Veteleanu, Aurora and Cramp, Hannah L and Bacon, Olivia G and Baillie, Kirsten L and Bright, Matthew and Cooke, Rebekah S and Fenn, Gareth D and Flores Castelán, Mariana and Lee, Kok Yung and Zelek, Wioleta M and Morgan, B Paul and Daskoulidou, Nikoleta},
title = {Clusterin is enriched in plaque‐associated astrocytes and localizes to synapses in Alzheimer's disease},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {10},
doi = {10.1002/alz.71885}
}
EUVIMED